NCT04057053View on ClinicalTrials.gov

Netarsudil Use After Descemetorhexis Without Endothelial Keratoplasty

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 2, 2018

Primary Completion Date

December 20, 2020

Study Completion Date

December 20, 2020

Conditions
Fuchs' Endothelial DystrophyCataract
Interventions
DRUG

Netarsudil 0.02% Ophthalmic Solution

Use of Netarsudil 0.02% ophthalmic solution daily after surgery

Trial Locations (1)

02114

Massachusetts Eye and Ear Infirmary, Boston

All Listed Sponsors
lead

Massachusetts Eye and Ear Infirmary

OTHER

NCT04057053 - Netarsudil Use After Descemetorhexis Without Endothelial Keratoplasty | Biotech Hunter | Biotech Hunter